<DOC>
	<DOCNO>NCT00319917</DOCNO>
	<brief_summary>The purpose study assess efficacy joint damage safety RA patient treat DMARDs double blind , placebo control study .</brief_summary>
	<brief_title>A Double Blind Placebo Controlled Study Assess Efficacy Joint Damage RA Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Clinically diagnose rheumatoid arthritis revise ACR criterion Those treated adequate stable dose either methotrexate , salazosulfapyridine bucillamine Those least one erosion Xray hand , wrists foot Those treat biologic drug leflunomide Those meet Class 4 Steinbrocker functional classification</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Tacrolimus anhydrous</keyword>
</DOC>